David Schubert

Company: Roche

Job title: Principal Scientist

Seminars:

A Novel IgG-IL2 Mutein to Selectively Activate T Regulatory Cells 2:45 pm

• Design and development of an IL-2 mutein showing Treg specificity • Assessment of Treg pharmacology in vitro and in vivo in non-clinical studies • Path towards clinical development of Treg therapies using IL-2 muteinsRead more

day: Day One